Markets

Incyte (INCY) Shows Strength: Stock Adds 7.2% in Session

Incyte CorporationINCY was a big mover last session, as its shares rose over 7% on the day. The upside was driven by the announcement that new data from the comapny's investigational immuno-oncology portfolio will be presented at the Society for Immunotherapy of Cancer (SITC) 30th Anniversary Annual Meeting & Associated Programs to be held from Nov 4-8, 2015 at the Gaylord National Resort & Convention Center in National Harbor, MD. This also led to far more shares changing hands than in a normal session. Yesterday's rally breaks the trend for the company since Sep 18, as the stock is now trading above the volatile range of $95.16 to $125.93.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday's jump can turn into more strength down the road.

Incyte currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #1 (Strong Buy).

Is INCY going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

INCYTE CORP (INCY): Free Stock Analysis Report

ANIKA THERAPEUT (ANIK): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIK INCY

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More